Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 25, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - June 25, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/25/17 - AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid
VIENNA and TAIPEI, Taiwan, June 25, 2017/ PRNewswire/ AOP Orphan Pharmaceuticals AG and PharmaEssentia Corporation announced latest results from 3 clinical studies on Ropeginterferon alfa-2b for patients with Polycythemia Vera presented at EHA 2017.. Ropeginterferon alfa-2b is a novel, long-acting, mono-pegylated proline interferon expected to be
6/25/17 - Dasatinib excels in worldwide phase II trial against pediatric CML
By a News Reporter-Staff News Editor at VerticalNews Science In 2002, the FDA approved the drug imatinib as a first-line therapy for adults with chronic myeloid leukemia caused by the fusion gene BCR-ABL, known as the Philadelphia chromosome. Now worldwide phase II clinical trial results presented at the American Society for Clinical Oncology Ann
6/25/17 - Data on Diabetes Detailed by Researchers at University of North Carolina (The Role of the FDA and Regulatory Approval of New Devices for Diabetes...
Data on Diabetes Detailed by Researchers at University of North Carolina. According to news reporting originating from Chapel Hill, North Carolina, by NewsRx correspondents, research stated, "Purpose of Review The Food and Drug Administration is responsible for assuring the safety, effectiveness, and quality of medical devices in the USA.
6/25/17 - Drug firms' gifts linked to docs' choices; Physicians likely to favor remedy; of company doling out freebies
Aaron Mitchell, lead researcher for the study. "This raises the possibility that drug companies are able to influence prescribing practices through gifts to physicians," said Mitchell, a fellow with the University of North Carolina School of Medicine. Richard Schilsky, chief medical officer of the American Society of Clinical Oncology, was not sur
6/25/17 - IDEAS study spurs related research to impact dementia care
By a News Reporter-Staff News Editor at VerticalNews Health& Science Washington, DC and Chicago, The milestone Imaging Dementia- Evidence for Amyloid Scanning Study is working with government and academic researchers to launch three add-on studies to expand the impact of the core study where more than 18,000 people with cognitive decline but an u
6/25/17 - Investigational vaccine protected monkeys from HIV-like virus
By a News Reporter-Staff News Editor at VerticalNews Health DURHAM, N.C. Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus. "The vac
6/25/17 - Lenvatinib Demonstrates Positive Results vs Sorafenib Across All Endpoints in First-Line Phase 3 Non-inferiority Trial of Unresectable Hepatocellular...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Eisai Inc. announced results from the REFLECT study, a Phase 3 trial evaluating lenvatinib, the company's multiple receptor tyrosine kinase inhibitor, for the first-line treatment of patients with unresectable hepatocellular carcinoma. These data will be presented in an oral..
6/25/17 - New FDA-Cleared Smart Heart Monitor Keeps the Cardiologist a Heartbeat Away
By a News Reporter-Staff News Editor at Heart Disease Weekly Eko Devices, the leader in mobile acoustic cardiac monitoring tools, has received FDA clearance to market its latest innovation, DUO- a combined digital stethoscope and electrocardiogram. The portable cardiac device was inspired by cardiologists' demand for more effective monitoring too
6/25/17 - OPIOID CRISIS Are drug companies responsible? States file lawsuits against pharmaceutical firms to recoup costs
PORTSMOUTH- Much of the country, including New Hampshire and Maine, is struggling with an unprecedented crisis- people addicted to heroin and other synthetic opioids. Dan Tierney, spokesperson for the Ohio Attorney General's office, said the suit, filed May 31, is the second filed by a state against pharmaceutical companies. The lawsuit, filed in R
6/25/17 - Patent Issued for Enalapril Formulations (USPTO 9669008)
By a News Reporter-Staff News Editor at Heart Disease Weekly Silvergate Pharmaceuticals, Inc. has been issued patent number 9669008, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. This patent was filed on March 25, 2016 and was published online on June 6, 2017. According to the National Heart Blood and Lun
6/25/17 - PORTSMOUTH - Much of the country
PORTSMOUTH- Much of the country, including New Hampshire and Maine, is struggling with an unprecedented crisis- people addicted to heroin and other synthetic opioids. Dan Tierney, spokesperson for the Ohio Attorney General's office, said the suit, filed May 31, is the second filed by a state against pharmaceutical companies. The lawsuit, filed in R
6/24/17 - Alcyone Lifesciences, Lowell, Mass., Assigned Patent for Drug Delivery Systems
Alcyone Lifesciences, Lowell, Massachusetts, has been assigned a patent developed by four co-inventors for "drug delivery systems and methods." The co-inventors are P.J. Anand, Lowell, Massachusetts, Morgan Brophy, Somerville, Massachusetts, Deep Arjun Singh, Cambridge, Massachusetts, and Greg Eberl, Acton, Massachusetts. Written by Amal Ahmed; edi
6/24/17 - Amid Reports That President Trump Will Break Promise to Get Tough on Drug Pricing, Sens. Booker, Franken, Lawmakers Urge President Trump to Act on Solutions That Bring Down Prescription Drug Costs
With news reports indicating the White House is on the verge of issuing an executive order devoid of policies that would meaningfully reduce prescription drug prices, breaking yet another key promise to Americans, Sen. Cory Booker joined Sen. Al Franken and other Senate and House Democrats to urge President Donald Trump to act on solutions that tru
6/24/17 - As White House Prepares Gift to Big Pharma, Sen. Franken, Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs
The office of Sen. Al Franken, D- Minn., issued the following news release:. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedly favors the industry over consumers, Sen. Al Franken led a wide group of Senate and House Democrats in pushing President Donald Trump to get behind real solutions to
6/24/17 - BARDA Gives Notice of Intent to Exercise First Contract Option to Further Fund MediWounds NexoBrid Development [T-break Tech (Middle East)]
MediWound Ltd., a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound management, announces that it received from the U.S. Biomedical Advanced Research and Development Authority a written Notice of Intent to exercise an option to fund further research and development...
6/24/17 - Bipartisan Group of Senators Urge FDA Commissioner to Address Prescription Drug Costs
Commissioner Gottlieb recently stated that the FDA will take measures to curb anticompetitive abuses of its regulatory process for the approval of generic drugs. In their letter, the senators advocate for their legislative solution and ask Commissioner Gottlieb to detail the regulatory actions the FDA can and cannot take to address strategies that.
6/24/17 - Collegium Pharmaceutical, Canton, Mass., Assigned Patent for Tamper-Resistant Pharmaceutical Compositions
Collegium Pharmaceutical, Canton, Massachusetts, has been assigned a patent developed by five co-inventors for "tamper-resistant pharmaceutical compositions of opioids and other drugs." The co-inventors are Roman Rariy, Philadelphia, Alison Fleming, Mansfield, Massachusetts, Jane C. Hirsh, Wellesley, Massachusetts, Said Saim, New Milford, Connectic
6/24/17 - Development of New Alzheimer's Drugs Lagging, Cleveland Clinic Report Finds
Alzheimer's disease drug development: pipeline 2017 is Cleveland Clinic's second annual review of Alzheimer's disease drug development and appears in the journal Alzheimer's& Dementia: Translational Research& Clinical Trials Interventions. "The purpose of presenting our annual findings is to help better understand the status of Alzheimer's disease
6/24/17 - FDA Approves CSL Behring`s Self-Administered C1 Esterase Inhibitor HAE Prophylactic [Syrian Arab News Agency]
The FDA approved CSL Behrings subcutaneously administered C1 esterase inhibitor, Haegarda, for routine use in preventing hereditary angioedema attacks in adolescent and adult patients. The FDA approval of Haegarda is an important milestone for the HAE community because it addresses the primary need of patients: to effectively prevent debilitating H
6/24/17 - FDA rejects Pfizer`s Epogen biosimilar for the second time [Arab Finance (Egypt)]
This time around, an FDA complete response letter cited concerns about the same Pfizer fill-finish plant whose problems led the FDA to deny approval of a highly anticipated copy of Tevas Copaxone that was to be finished there. Pfizer late Thursday announced the FDA had issued the CRL for its proposed epoetin alfa biosimilar, a drug that has been on
6/24/17 - Glia, Boston, Assigned Patent for Cranial Delivery of Pharmaceuticals
Glia, Boston, has been assigned a patent developed by two co-inventors for "cranial delivery of pharmaceuticals." The co-inventors are Kenneth I. Sawyer, Cushing, Maine, and Wei-wei Chang, Boston. Written by Kusum Sangma; edited by Sudarshan Harpal.
6/24/17 - Holding Them Accountable: County to Pursue Lawsuit Against Pharma Firms That Made, Marketed Dangerous Opiate-Based Rx Drugs
Niagara County issued the following news release:. Niagara County joined the growing ranks of counties seeking to hold drug companies accountable for the heavy costs arising from opiate-based pharmaceuticals Tuesday, reacting to an opioid and heroin epidemic plaguing Western New York and the nation at large. Majority Leader Randy R. Bradt, R- North
6/24/17 - Horizon Pharma plc Completes Sale of European Marketing Rights for PROCYSBI (cysteamine bitartrate) delayed-release capsules and QUINSAIR (levofloxacin nebuliser solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farmaceutici S.p.A.
-Horizon Pharma plc, a biopharmaceutical company focused on improving patients lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has completed the sale of a European subsidiary that owns the marketing rights to PROCYSBI delayed-release...
6/24/17 - Licensing Agreements Target Spinal Cord Injury, Cancer
The University of Texas Health Science Center at San Antonio issued the following news release:. UT Health San Antonio and UT Health Houston announced agreements June 23 to grant exclusive global licenses for two unique biologic therapeutics to AlaMab Therapeutics Inc., a subsidiary of CSPC Pharmaceutical Group Ltd. The biologics will be developed
6/24/17 - Mailbag: The darker side of price parity
Having been employed by the pharmaceutical industry for some years, I can attest that many countries outside the United States, particularly the poorest ones, are able to purchase U.S. drugs far less expensively than they are sold to American consumers. The reason drugs are sold more cheaply elsewhere is because after the enormous expense of develo
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415